Blog

Member of the APCaRI Training Program, Dr. Lian Willetts, wins AUM Science and Innovation Award!

Dr. Willetts was awarded for her compelling and extraordinary research in the area of  MicroRNAs and Noncoding RNAs in Cancer.

Through this support, Dr. Willetts at Dr. John Lewis’s laboratory, will have access to AUM’s next generation oligonucleotide technology that can be used to further awardee’s research.

Congratulations Lian!

New platform for prostate cancer diagnosis to be presented at ISEV 2017

The Lewis Research Group will present exciting results about new blood tests for prostate cancer during 3 talks at the upcoming 2017 International Society of Extracellular Vesicles (ISEV) annual meeting in Toronto (May 18-21). ISEV is a global society of researchers studying exosomes and microvesicles, which are the exciting new focus of cancer therapy and diagnosis.

Dr. Desmond Pink will speak about “Microflow cytometry: The Apogee A50 is a sensitive standard tool for extracellular vesicle analyses in liquid biopsies”, Robert Paproski’s presentation is entitled “Using machine learning of extracellular vesicle flow cytometry to build predictive fingerprints for prostate cancer diagnosis”, and Dr. John Lewis will speak about “An extracellular vesicle blood fingerprint distinguishes between patients with indolent and aggressive prostate cancer at diagnosis”.

The team is looking forward to sharing these key advances that were made possible through the APCaRI prospective cohort.

- John Lewis